0.00Open0.00Pre Close0 Volume0 Open Interest10.00Strike Price0.00Turnover96.10%IV-20.45%PremiumOct 18, 2024Expiry Date2.57Intrinsic Value100Multiplier20DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.8714Delta0.0736Gamma4.49Leverage Ratio-0.0158Theta0.0045Rho3.91Eff Leverage0.0062Vega
Perspective Therapeutics Stock Discussion
Larger Image: tradingview.com...
$Perspective Therapeutics (CATX.US)$
$Perspective Therapeutics (CATX.US)$
1:10
$Virgin Galactic (SPCE.US)$ 1:20
$Star Equity (STRR.US)$ 1:5
$Workhorse (WKHS.US)$ 1:20
FDA Selects Perspective Therapeutics To Participate In The CDRP Program To Expedite Chemistry, Manufacturing, and Controls Development Readiness For VMT-α-NET in Neuroendocrine Tumors
The Zhitong Finance App learned that the market value of the Richland, Washington-based company has increased about four times this year to reach US$833 million. Amid the radiopharmaceuticals (also...
No comment yet